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Purpose: Some individuals with chronic pain find daily life sensations (eg, noise, light, or 
touch) aversive. This amplification of multisensory sensations has been associated with 
centrally mediated plasticity; for example, greater multisensory sensitivity (MSS) occurs in 
patients with fibromyalgia than rheumatoid arthritis. However, whether MSS preferentially 
relates to pain measures which reflect central influences (eg, dynamic quantitative sensory 
testing (QST) or referred pain), or whether the MSS-pain relationship requires priming from 
chronic pain, is unknown. Thus, this cross-sectional study investigated the relationships 
between MSS assessed in a pain-free state and evoked pain sensitivity.
Methods: Experimental intramuscular infusion pain and multiple static and dynamic QST 
were assessed in 465 healthy, pain-free adults: pain thresholds using pressure (PPTs) and heat 
(HPTs), temporal summation of pain (TSP) using pressure, heat or punctate stimuli, and 
conditioned pain modulation (CPM) using pressure or heat test stimuli. MSS was assessed 
using 7 items from Barsky’s Somatosensory Amplification Scale. Differences in pain and 
QST between sex-specific MSS quartiles were assessed, adjusting for multiple comparisons. 
All participants completed at least one intramuscular infusion condition, but not all were 
asked to complete each QST (n=166-465).
Results: Both static and dynamic QST differed between highest and lowest MSS quartiles 
using pressure stimuli: lower PPTs (adjusted-p<0.01); increased pressure TSP (adjusted- 
p=0.02); lower pressure CPM (adjusted-p=0.01). However, none of the heat or punctate QST 
measures (HPTs, TSP, or CPM) differed between MSS quartiles (adjusted-p>0.05). Odds of 
experiencing TSP or referred pain was not greater, whereas CPM was 8-fold less likely, in 
those with highest MSS.
Conclusion: Normal variation in non-noxious MSS is related to both static and dynamic 
pain sensitivity, without sensitization associated with chronic pain, but is dependent on the 
QST stimulus. Thus, common influences on MSS and pain sensitivity may involve central 
mechanisms but are likely more complex than previously recognized.
Keywords: pain sensitivity, somatosensory amplification scale, experimental muscle pain, 
quantitative sensory testing, temporal summation of pain, conditioned pain modulation
Plain Language Summary
Heightened sensitivity to multiple senses, eg, bright lights, noises, strong perfumes, or 
clothing tags, is referred to as multisensory sensitivity (MSS) and has been observed in 
several chronic pain cohorts, particularly conditions thought to be driven by central mechan-
isms. These observations suggest that there may be a link between MSS and pain. However, 
whether this link only appears after adaptations that occur in the central nervous system in 
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response to chronic pain, or whether it may be present even in 
pain-free adults was unknown. To test this, multiple pain sensi-
tivity assessments were performed, including evoked measures of 
pressure, heat, punctate, and acidic muscle pain as well as 
a measure of MSS using items from an existing survey, the 
Somatosensory Amplification Scale, controlling for negative per-
sonality trait (ie, Neuroticism). We found that people with greater 
MSS tend to experience higher deep-tissue (eg, pressure) but not 
cutaneous (eg, heat) pain sensitivity. These findings indicate that 
the link between MSS and pain sensitivity does not require 
priming from chronic pain. Further, this relationship between 
pain sensitivity and MSS was not simple, but varied across test 
modalities. These results support the conclusion that elevated 
MSS can precede the development of chronic pain, and is not 
necessarily a consequence of chronic pain central nervous system 
adaptations. Thus, the MSS-pain relationship is more complex 
than previously recognized.
Introduction
Chronic pain affects over 100 million in the US alone.1 It 
is increasingly recognized that many clinical pain patients 
may involve combinations of nociceptive, nociplastic, and/ 
or neuropathic contributors.2–5 In particular, sensitization 
of central pain mechanisms, associated with nociplastic 
pain, likely contributes to the development and/or main-
tenance of chronic pain.4,5 Because central mechanisms 
and nociplastic changes cannot be assessed directly in 
humans, they are typically inferred as greater pain sensi-
tivity using dynamic quantitative sensory testing (QST) 
relative to healthy individuals.4–8 More specifically, 
dynamic QST includes assessment of temporal summation 
of pain (TSP) and conditioned pain modulation (CPM). 
TSP refers to a wind-up response of C fibers to repetitive 
activation in animal models9 and has been well accepted as 
a psychophysical measure of net central facilitation of 
human pain in clinical settings.6,7 Similarly, CPM, which 
is psychophysically associated with diffuse noxious inhi-
bitory controls,10 has been widely accepted as a measure 
of net endogenous descending inhibition of human pain in 
practice.6,7
Emerging evidence suggests multisensory sensitivity 
(MSS) could potentially serve as an additional marker to 
reflect the status of CNS sensitivity as elevated MSS has 
been theorized to be attributable to a sensitized CNS.11–14 
Indeed, a review showed pre-morbid assessments of high 
sensory sensitivity using QST were predictors of central 
sensitization.14 Several pain populations, suspected to 
involve central mechanisms or nociplastic pain, report 
hypersensitivity to normal daily sensations, such as light 
touch, bright light or noise. For instance, patients with 
fibromyalgia reported greater MSS than a similar cohort 
of women with rheumatoid arthritis.12 Similarly, others 
report abnormally heightened sensory sensitivities (ie, 
phonophobia and photophobia) in people with 
fibromyalgia,13,15 complex regional pain syndrome,16 and 
migraine patients particularly during attacks17,18 compared 
to pain-free, control populations. These studies suggest 
that elevated MSS could be linked to chronic pain. 
However, it is unknown whether the link between MSS 
and pain develops in response to chronic pain, eg, due to 
nociplastic adaptations in the CNS, or may be present prior 
to the onset of a painful condition.
While elevated MSS assessed by various instruments 
has been observed in approximately 5–20% of healthy, 
pain-free individuals,19,20 demonstrating normal variabil-
ity, it is not clear the degree to which non-noxious MSS is 
related to various assessments of pain sensitivity in either 
healthy or clinical pain populations. For example, prior 
studies report mixed findings on the relationships between 
thermal pain sensitivity and non-noxious sensory 
sensitivity.11,13,21 However, if MSS is related to chronic 
pain due to underlying shared central mechanisms as pre-
viously suggested,11,12,14 then one might expect MSS to be 
more closely related to dynamic QST and referred pain, 
both associated with central mechanisms,5–7,22 than to 
static QST or local pain. Unfortunately, studies are lacking 
that consider multiple QST modalities (eg, thermal and 
mechanical) using both static (thresholds) and dynamic 
(temporal summation or conditioned pain modulation) 
assessments or controlled experimentally induced pain 
models. In order to better understand the relevance of 
MSS in chronic pain, it is important to first determine 
the extent to which heightened multiple sensory sensitivity 
is related to pain sensitivity pre-morbidly. The use of 
a QST battery and experimental muscle pain in a healthy 
pain-free cohort provides an efficient way to investigate 
baseline associations between MSS and pain sensitivity, 
using clinically relevant measures while minimizing the 
potential confounding effects of patient-variation due to 
disease duration or underlying levels of pathology.
Accordingly, the primary purpose of this study was to 
assess the degree to which elevated MSS was associated 
with heightened pain sensitivity in previously pain-free 
adults, using a comprehensive battery of experimental 
muscle pain and QST measures. We hypothesized that 
individuals with heightened MSS would demonstrate 
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greater dynamic than static QST pain sensitivity overall 
and greater risk of referred pain compared to those with 
low MSS. Our secondary aim was to evaluate for sex 
differences in these relationships, as women are greatly 
overrepresented in many chronic pain syndromes,23 and 




All participants were recruited from the University and 
surrounding local community to participate in a study 
aimed at assessing predictors of muscle pain. A range of 
recruitment techniques were used, including posted flyers, 
ads in the University medical center daily lunch news-
letter, an online listing of available studies, mass emails 
to University graduate students and staff, and word of 
mouth. Study inclusion criteria included: English-fluent, 
pain-free; ages from 18–55 years; and no history of 
chronic pain. Exclusion criteria included: significant med-
ical conditions (eg, cardiac, asthma, rheumatologic, can-
cer, etc.); taking any medications other than birth control, 
allergy medications or multi-vitamins; significant self- 
reported psychiatric disorders; and history of significant 
musculoskeletal injuries, as previously described.25 To be 
included in these analyses, additional inclusion criteria 
included completion of: at least one experimental muscle 
pain visit, the Somatosensory Amplification Scale 
(SSAS),26 and the Eysenck Personality Questionnaire- 
Revised (EPQ-R).27 Thus, 491 individuals were recruited 
for the overall muscle pain study with 465 meeting these 
additional analyses criteria. However, the specific sample 
sizes of QST pain sensitivity measures varied from 166 to 
463 (Figure 1) as some QST assessments (eg, heat pain 
threshold (HPT), temporal summation of pain (TSP), con-
ditioned pain modulation (CPM)) were added later in the 
study protocol.
Ethics Approval
This study was approved by the University of Iowa 
Biomedical Institutional Review Board (IRB approval 
#200604757) for the protection of human subjects in com-
pliance with federal human subjects regulations. Written- 
informed consent prior to participation was obtained, as 
approved by the IRB. All participants were reimbursed for 
their time.
Study Design
This is secondary analyses of an observational, cross- 
sectional study investigating factors associated with 
experimental muscle pain. Preliminary results are pub-
lished elsewhere.25,28 Individuals participated in up to 3 
visits to complete a series of surveys, exogenous anterior 
tibialis muscle pain, and QST pain sensitivity measures: 
pain thresholds, TSP and CPM, using pressure, heat and 
punctate stimuli. The surveys, the experimental muscle 
pain, and lower limb pressure pain thresholds (PPTs) 
were assessed in visits 1 and 2. A more comprehensive 
battery of QST was added as a third visit (see below), 
following a protocol revision part-way through the study. 
Accordingly, the sample size is largest for the experimen-
tal muscle pain and lower limb PPT outcomes and reduced 
for the remaining QST outcomes (Figure 1). General 
demographic information was collected as part of the 
surveys, including age, sex, height, weight, and general 
health. Body mass index (BMI) was computed from 
weight and height.
Multisensory Sensitivity Assessment
Non-noxious MSS was assessed using Barsky’s 
Somatosensory Amplification Scale (SSAS) (Table 1).26 
The SSAS assesses sensory amplification, or the tendency 
to perceive normal daily external or internal bodily sensa-
tions as being particularly unpleasant or bothersome, and 
has been used in various healthy and patient populations 
including pain patients.26,29–32 While this tool is some-
times used to assess symptom magnification, also referred 
to as hypochondriasis,32 it was originally described as 
assessing “perceived sensitivity to several unpleasant bod-
ily sensations”.26 The SSAS assesses multiple sensory 
systems, including somatic sensations, temperature, olfac-
tory, and auditory sensitivity. Participants were asked to 
rate the degree to which each statement was true for them 
on a 5-point Likert scale, ranging from 1 (“not at all true”) 
to 5 (“extremely true”). For example, items included: 
“Sudden loud noises really bother me,” and “I hate to be 
too hot or too cold.” While the original SSAS includes 10- 
items, only 7 were summed for use as a measure of MSS 
(Table 1). Three items, “When someone else coughs, it 
makes me cough too;” “When I bruise myself, it stays 
noticeable for a long time;” and “I have a low tolerance for 
pain;” were assessed, but excluded from the current ana-
lysis as they are either less clearly relevant to MSS (eg, 
individuals may have physiologic reasons for bruising 
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more easily, and coughing is not a sensory sensitivity) or it 
specifically assesses pain. We did not want to include 
a pain sensitivity item, and only include non-noxious 
MSS items, to minimize the risk of artificially elevating 
the associations between sensory sensitivity and pain 
sensitivity.
The original SSAS has been translated into multiple 
languages and has shown good internal consistency and 
test-retest repeatability.26,33,34 The sum of the 7-items had 
a total possible score ranging from 7 to 35, where higher 
scores indicate higher non-noxious somatosensory ampli-
fication. Scores were categorized into sex-specific quar-
tiles, as women typically report higher multisensory 
sensitivity than men,11,24 enabling high vs low somatosen-
sory amplification comparisons while adjusting for sex 
differences. Using the current dataset, the 7-items resulted 
in McDonald’s Omega = 0.79, generally accepted as good 
internal consistency.35
To adjust for the potential confound of negative emo-
tionality when assessing relationships between pain sensi-
tivity and MSS, neuroticism was measured using the 
Eysenck Personality Questionnaire – Revised (EPQ-R), 
a standard personality instrument.27 The EQP-R 
Neuroticism subscale consists of 24 yes or no items that 
assess multiple aspects of negative emotionality. Higher 
scores indicate a personality type that is characterized as 
more anxious, fearful, and worrisome. The EPQ-R 
Neuroticism scale has demonstrated good reliability coef-




Visits 1 & 2: 
Experimental Muscle Pain 
(Acidic buffer: 40, 80 ml/hr






































Figure 1 The schematic study design framework of the pain sensitivity assessments and associated sample sizes. 
Abbreviations: PPT, pressure pain threshold; HPT, heat pain threshold; TSP, temporal summation of pain; CPM, conditioned pain modulation.
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Experimental Muscle Pain
Intramuscular infusions into the mid-belly portion of the 
left anterior tibialis muscle were used to assess experimen-
tal muscle pain using two solutions at two infusion rates. 
Acidic (pH 5.2) phosphate buffer (ie, acidic condition) or 
0.9% isotonic saline (ie, saline condition) were infused at 
separate visits at both 40 mL/h for 5 min and 80 mL/h for 
5 min with a two-minute washout period between rates, 
similar to previously reported methodology but with the 
addition of a faster rate.25 The study protocol initially used 
20 and 40 mL/h rates for 15 min each at separate visits, 
but due to low pain ratings was changed to 40 and 80 mL/ 
h at a single visit for only 5 min each as peak pain 
occurred within 3–4 min. The order of the acidic vs saline 
infusions between visits, as well as the 40 versus 80 rate 
within each visit, was block randomized by assigned sub-
ject number, and balanced between men and women.
Anterior tibialis infusion models typically elicit mild to 
moderate muscle soreness locally at the infusion site (ante-
rior shin) and referred pain at the anterior ankle joint.22,25 
While local pain evoked by intramuscular infusion likely 
is a result of predominately peripheral hyperalgesia, 
referred pain is believed to be a centrally mediated phe-
nomenon, a form of sensitized central pain 
mechanisms.5,22 Experimental muscle pain is rate 
dependent,25,37 thus the faster rate (80 mL/hr) conditions 
were expected to induce greater pain than the slower rate 
(40 mL/hr). Further, the buffered acidic condition is typi-
cally more painful than normal saline as it is thought to 
activate acid sensing ion channels,25,38 whereas the saline 
condition only induces mechanical distension. Thus, the 
four conditions provide varying levels of intramuscular 
painful stimuli, from very low (saline 40 mL/h) to moder-
ate (acidic 80 mL/h) pain. This provides a means to assess 
muscle pain sensitivity across a range of controlled 
stimuli.
Pain ratings were verbally assessed every 30 s during 
the infusions using a verbal 0–10 scale (Borg CR10 
scale),39 where 0 represented “no pain at all” and 10 
signified “the maximum pain they have ever imagined”. 
Participants could rate their pain with fractions or decimals 
if they chose. Participants were asked to rate both their 
local pain (“at the infusion site”) and referred pain (“at the 
ankle”). The peak pain ratings for the local and referred 
pain sites were extracted for each condition. The Borg 
CR10 scale has been shown to be a valid instrument to 
measure pain intensity.39
Pressure and Heat Pain Thresholds
Pressure pain thresholds (PPTs) were measured using 
a digital, hand-held pressure algometer (Somedic AB, 
Farsta Sweden) with a standard 1 cm2 rubber-tipped 
probe at a rate of 30 kPa/s. Participants were instructed 
to press a hand-held trigger when they first felt pain from 
the pressure (“approximately 1 out of 10 pain”). Only 
baseline PPTs (prior to the intramuscular infusion) were 
considered in the current analyses. Multiple locations were 
assessed: the anterior tibialis muscle belly, averaging mea-
sures from just above and below the infusion site; the web 
space between the 1st and 2nd metatarsals on the ipsilat-
eral foot, and the middle deltoid muscle belly of the left 
arm (assessed during the third QST visit, see Figure 1). 
The average of four baseline repetitions was used as the 
PPT value for the anterior tibialis and foot; two pre- and 
two post-catheter insertions as they were not significantly 
different across time. The average of three repetitions was 
used for the deltoid PPT location. Subjects were familiar-
ized with the PPT assessment using one practice round at 
each site prior to data collection.
Heat pain thresholds (HPTs) were measured on the left 
thenar eminence of the hand (thumb) using a computer- 
controlled TSA-II Neurosensory Analyzer (Medoc II, 
Israel) and a 16 x 16 mm Peltier thermode to determine 
cutaneous thermal pain sensitivity. The temperature was 
Table 1 Seven Items (Unshaded) from the 10-Item Somatosensory 
Amplification Scale (SSAS) Used to Assess Multisensory Sensitivity
Individual Items of SSAS
When someone else coughs, it makes me cough too.
I cannot stand smoke, smog, or pollutants in the air.
I am often aware of various things happening within my body.
When I bruise myself, it stays noticeable for a long time.
Sudden loud noises really bother me.
I can sometimes hear my pulse or my heartbeat throbbing in my ear.
I hate to be too hot or too cold.
I am quick to sense the hunger contractions in my stomach.
Even something minor, like an insect bite or a splinter, really bothers me.
I cannot stand pain.
Notes: Grey highlighted items were not included in the non-noxious somatosen-
sory amplification score for the current study. Reprinted from Journal of Psychiatric 
Research, 24(4), Barsky AJ, Wyshak G, Klerman GL, The somatosensory amplifica-
tion scale and its relationship to hypochondriasis, 323-334, Copyright (1990), with 
permission from Elsevier.26
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increased at a rate of 0.5°C/s from a baseline temperature 
of 39°C to a maximum temperature of 52.5°C. Participants 
were instructed to press a computer mouse button when 
they first felt pain from the heat stimulus (“approximately 
1 out of 10 pain”). HPTs were computed as the average of 
three trials with 5 s intervals between each, following one 
practice trial for familiarization.
Pressure, Heat, and Punctate Temporal 
Summation of Pain
Temporal summation of pain (TSP) was assessed as the 
human analog to wind-up, to indirectly assess CNS facil-
itation of pain.9,40 Numerous evidence supports that TSP 
can be induced if the frequency of nociceptive stimuli is 
equal to or greater than 0.33 Hz.41–45 TSP was assessed 
using three modalities: pressure, heat, and punctate sti-
muli. Each stimulus was applied at a frequency of 0.5 
Hz46–49 for 30 seconds (ie, 15 repetitions). Participants 
were instructed to rate their pain intensity initially (after 
2 repetitions), again mid-way (15 seconds), after the final 
stimulation (30 seconds) and any after sensations (45 
seconds and 60 seconds) using the 0–10 pain scale.39 
TSP was computed as the peak pain minus the initial 
pain, where positive values (ie, increased pain) represents 
presence of TSP.
To assess pressure TSP, a custom device was used to 
apply a deep-tissue mechanical stimulus with a 1 cm2 
rubber tip over the extensor carpi radialis brevis muscle 
on the left dorsal forearm. The pressure stimulus (ie, force 
applied) was individually determined for each participant 
targeting pain ratings of 3 out of 10, assessed prior to 
starting the TSP test. Heat TSP was assessed using repe-
titive-phasic heat stimuli applied on the volar side of the 
left forearm using the 16 x 16 mm Medoc TSA-II probe. 
The pre-programmed heat TSP protocol varied the tem-
perature from a baseline of 41°C to the destination tem-
perature of 49°C at a rate of 10°C/s. Punctate TSP was 
performed using a 300g von Frey filament applied to the 
volar side of the left wrist. The same rate (1 sec on:1 sec 
off), number of stimuli (n=15) and pain assessments (0–10 
pain scale) were used for each TSP procedure.
Pressure and Heat Conditioned Pain 
Modulation
Conditioned pain modulation (CPM) is the human analog to 
diffuse noxious inhibitory controls (DNIC), an indirect mea-
sure of descending pain inhibition.50 It was assessed as the 
reduction in pain sensitivity to a test stimulus at a remote site 
following a conditioning pain stimulus. Pressure CPM was 
assessed using the mean of 3 PPTs of the left deltoid muscle 
as the test stimuli; heat CPM was assessed using the mean of 
3 HPTs at the left thenar eminence as the test stimuli (same 
upper extremity locations used for PPTs and HPTs described 
above). For both pressure and heat CPM, the conditioning 
stimulus was right hand immersion to the wrist in circulating 
0–2°C water for 1 min (or as tolerated). CPM was computed 
as the difference in mean pain thresholds (immediately 
post – pre-conditioning values). A positive value (increased 
pain threshold) indicated the presence of CPM (ie, centrally 
mediated pain inhibition). A minimum 5 min washout inter-
val separated the two CPM tests to allow subjects to recover 
from the prior cold-water hand immersion. The order of 
QSTs was block randomized between modalities within 
each class of QST (ie, heat vs pressure or punctate) but 
thresholds were always tested first, followed by TSP, and 
finally CPM to minimize the likelihood that the more intense 
cold-water immersion influenced threshold or summation 
responses.
Statistical Analyses
All values are presented in the text as mean ± standard 
deviation (SD), medians and interquartile ranges (IQR), or 
proportions unless otherwise noted. MSS sex-specific 
quartiles were computed; each participant was assigned 
to one sex-specific quartile classification, where 1st quar-
tile represented the lowest and 4th quartile represented the 
highest sensory sensitivity groupings. This was done to 
enable comparisons between groups of individuals to be 
performed based on their MSS levels. Demographic vari-
ables were compared between sexes and across MSS 
quartiles using analysis of variance (ANOVA) or Chi- 
Square (X2) tests as appropriate. All statistical analyses 
were performed using SAS 9.4 (SAS Institute, USA) 
with significance set at p<0.05.
Differences in pain sensitivity outcomes (dependent vari-
ables) were assessed between those in the highest three MSS 
quartiles relative to the reference (1st) quartile (independent 
variable) using generalized linear models (GLM). To test 
whether the MSS-pain sensitivity relationships differed 
between sexes, an omnibus test including an interaction 
term, ie, sex by MSS quartile, was initially performed. 
When there were no significant sex interactions, the GLMs 
were then repeated without the interaction term to optimize 
study power. All analyses were adjusted for a priori deter-
mined confounders (age, sex, BMI, and neuroticism). Model 
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residuals were tested for normality; when violated, Box Cox 
transformations of the study variables were applied as neces-
sary to appropriately meet normality assumptions. Outliers 
were identified using Q-Q plots and removed. Specifically, 
data points that were clearly separated from the reference 
line of the Q-Q plot were identified as outliers and removed 
from the data analyses. The GLM analyses were then 
repeated to ensure the residuals met normality 
assumptions.51 The false discovery rate (FDR) was used to 
adjust p-values for multiple comparisons.
Standardized effect sizes (Cohen’s d and 95th CI) were 
computed for each pain sensitivity outcome between the 
4th and 1st sex-specific MSS quartiles using transformed 
data as appropriate. Cohen’s d values were computed from 
adjusted least square (LS) means and SD using an online 
calculator (https://www.psychometrica.de/effect_size. 
html). Adjustment for unequal sample sizes was 
performed.52 Effect sizes were operationally defined 
using the following cut-off values for small (d ≥ 0.2), 
medium (d ≥ 0.5), and large (d ≥ 0.8) effect sizes.53
In addition to quartile comparisons, which assess for 
differences relative to a reference group, we used multiple 
regression to assess the linear nature of the relationship 
between continuous pain sensitivity outcomes (dependent 
variables) and MSS scores (independent variable). Again, 
the transformed pain sensitivity variables identified for the 
GLM analyses were used for the multiple regression, with 
age, sex, BMI, and neuroticism included as model covariates. 
Model coefficients of determination (R2), beta coefficients 
for MSS and associated p-values were assessed. Lastly, mul-
tiple logistic regression analyses were used to assess the odds 
of experiencing dichotomous pain sensitivity outcomes: pre-
sence of referred pain, presence of TSP, and absence of CPM 
for those in the highest versus the lowest MSS quartiles (4th 
versus 1st). This was assessed to evaluate whether MSS is 
associated with the presence/absence of central pain proces-
sing markers, as referred pain, TSP and CPM are described 
as indirect markers of a sensitized CNS.4,5
Results
Participant Demographics, MSS and Pain 
Sensitivity
Overall, 491 participants were recruited; 465 met the inclu-
sion criteria for these analyses. See Table 2 for summary 
demographic information of subjects included in data ana-
lyses. Overall, MSS scores were higher in women (19.1 ± 4.3) 
than men (17.5 ± 4.0, p = 0.0001), resulting in the approxi-
mately 1.5-point higher cut-off values for women across each 
quartile (see supporting materials Table S1). Age and neuroti-
cism differed across sex-specific MSS quartiles (p ≤ 0.01), but 
no differences in sex distribution, race, or BMI were observed 
(Table 2). People in the highest MSS quartile (the most 
sensitive to non-noxious sensory inputs) were significantly 
younger and had higher neuroticism scores than those in the 
lowest quartile (p ≤ 0.01). Demographic information on sub-
jects excluded from the analyses are presented in Table S2 and 
descriptive statistics for the observed cohorts and those with 
missing data are presented in Table S3.
Women showed higher pressure pain sensitivity (lower 
PPTs) than men at the anterior tibialis and deltoid sites 
(adjusted-p < 0.01, see supporting materials Table S4). 
Men reported slightly higher local muscle pain from the 
least noxious infusion condition, saline at 40mL/hr 
(adjusted-p = 0.04, Table S4). Whereas, despite similar 
local pain intensities, women were more likely to 
Table 2 Characteristics of Study Participants Overall and by MSS Sex-Specific Quartiles
All (N=465) MSS Sex-Specific Quartiles Quartile 
P-value
Mean (SD) or N (%) Range Q1 (n=129) Q2 (n=127) Q3 (n=107) Q4 (n=102)
Age 26.2 (7.7) 18–54 28.1a,b,c (9.0) 26.0a,b,c (7.6) 25.6b,c (6.7) 24.9b,c (6.8) 0.01
BMI (kg/m2) 24.6 (3.8) 17–41.3 25.1a (4.3) 24.4a (3.5) 24.8a (4.0) 24.0a (3.2) 0.17
Female 236 (50.8) - 60 (46.5) 77 (60.6) 50 (46.7) 49 (48.0) 0.08
Caucasian 404 (86.9) - 105 (81.4) 116 (91.3) 94 (87.9) 89 (87.3) 0.39
7-item SSAS 18.3 (4.2) 9–30 13.3a (1.9) 17.4b (1.0) 19.9c (1.2) 24.1d (2.3) <0.0001
EPQ-R Neuroticism 9.1 (5.1) 0–23 7.3a (5.0) 8.8b (5.0) 9.6b,c (4.6) 11.3d (5.1) <0.0001
Notes: Values with same upper letter (a, b, c, d) indicated no difference with each other. False discovery rate was used for multiple comparisons between MSS sex-specific 
quartiles (4th = highest sensory sensitivity; 1st = lowest sensory sensitivity). Mean (SD) or N (%) were presented if appropriate. The significant values for the ANOVA model 
were highlighted in bold (p≤0.05). 
Abbreviations: MSS, multisensory sensitivity; SSAS, somatosensory amplification scale; EPQ-R Neuroticism, Eysenck Personality Questionnaire-Revised Neuroticism.
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experience referred pain than men from the acidic infu-
sions: odds ratios 1.7 [1.1, 2.6] and 2.1 [1.2, 3.7] for 40 
and 80 mL/hr, respectively (see supporting materials, 
Table S5). No other pain sensitivity measures differed 
significantly between men and women.
There were no significant sex interactions with sex- 
specific MSS quartiles for all but two pain sensitivity 
outcomes: local muscle pain from saline infusion 
(80 mL/hr) and PPTs at the deltoid. Thus, for these two 
outcomes only, the models were analyzed with the inter-
action term in addition to adjusting for sex, BMI, age and 
neuroticism as covariates.
Experimental Muscle Pain
Local muscle pain intensity was greater for those in the 
highest (4th) than those in the lowest (1st) sex-specific 
MSS quartiles in only one of the four conditions: acidic 
infusion at 40 mL/hr (d = 0.43; adjusted-p = 0.01, Figure 2A 
and supporting materials, Table S6). Local muscle pain 
from the 80 mL/hr saline infusion showed different MSS- 
muscle pain relationships between men and women (sig-
nificant sex interaction, p = 0.01). Follow-up testing 
revealed women but not men showed significant differences 
in muscle pain between MSS quartiles (p = 0.05, d = 0.56, 
Table S6), after adjusting for multiple comparisons (Figure 
3A). However, there were significant linear trends (p < 
0.03) between MSS and experimental muscle pain for two 
conditions: saline and acidic infusions at 40 mL/hr.
Referred pain intensity was not compared across MSS 
quartiles using general linear modeling, as approximately 
21.6–54.5% of individuals did not report any referred pain 
across infusion conditions (see supporting materials Table 
S5). Thus, only odds ratios for the presence/absence of 
referred pain were assessed. However, the odds of experi-
encing referred pain during any of the infusion conditions 
was not significantly different between the extreme MSS 
quartiles (4th vs 1st; Figure 4).
Pain Thresholds
PPTs were significantly lower (higher pain sensitivity; 
adjusted-p < 0.007) in individuals in the two highest 
MSS quartiles at the anterior tibialis muscle (d = 0.59 
and 0.54), and in highest MSS quartile at the foot (d = 
0.43; Figure 2B and Table S6) compared to those in the 
lowest MSS quartile. However, at the deltoid, men and 
women showed different MSS – PPT relationships (ie, 
significant sex interaction with p = 0.04) with follow-up 
testing revealing that neither men or women showed 
significant differences in PPTs between MSS quartiles 
after adjusting for multiple comparisons (Figure 3B). 
Conversely, HPTs did not differ between MSS quartiles 
(adjusted-p = 0.71; Figure 2C). Similar findings were 
observed when evaluating for linear trends between pain 
thresholds and MSS (supporting materials, Table S6) 
where only PPTs at the lower limbs significantly varied 
with MSS scores.
Temporal Summation of Pain
Pressure TSP was significantly greater in those in the 
highest compared to the lowest sex-specific MSS quartiles 
(adjusted-p = 0.03, d = 0.57, Figure 2D and supporting 
materials, Table S6). However, neither heat nor punctate 
TSP differed significantly between MSS quartiles (p > 
0.35; Figure 2D and Table S6). Similarly, the linear trend 
analyses produced consistent results – only pressure TSP 
varied with MSS (Table S6). When assessing simply for 
the absolute presence/absence of TSP between MSS 
extreme quartiles using logistic regression, no significant 
differences were noted. However, the odds of experiencing 
punctate TSP for the highest vs lowest MSS quartiles 
approached significance: 2.36 [0.84, 6.65] (Figure 4).
Conditioned Pain Modulation
Pressure CPM was lower (ie, less pain inhibition) in those 
with the highest (4th quartile) versus those with the lowest 
(1st quartile) MSS scores (d = 0.67; adjusted-p = 0.01 
Figure 2E and supporting materials, Table S6). Again, 
however, no differences in heat CPM were observed 
between the highest versus the lowest somatosensory quar-
tiles (Figure 2F and Table S6). Further, the trend analyses 
produced similar results – only pressure CPM varied with 
MSS (Table S6). Finally, people with greater MSS (2nd, 
3rd, and 4th quartiles) were nearly three to eight times less 
likely to experience pressure CPM than those in the lowest 
(1st) quartile (Figure 4 and Table S7).
Discussion
This is the first study to examine the relationships between 
MSS and multiple measures of pain sensitivity. While pre-
vious research has shown heightened sensitivity to non- 
noxious stimuli in several chronic pain conditions, our results 
indicate self-reported MSS in the pain-free state is related to 
select QST measures without adapted neuroplastic changes 
from pre-existing pain conditions. Further, MSS is uniquely 
related to pressure QST assessments. No cutaneous (heat or 
punctate) pain sensitivity assessments were related to self- 
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Figure 2 Boxplots showing median (black bars) and 25th–75th percentiles (IQR boxes) of each pain sensitivity outcome by sex-specific MSS quartiles: (A) local pain ratings 
from 4 intramuscular infusion conditions; (B) pressure pain thresholds (PPT) at 3 sites; (C) heat pain thresholds (HPT); (D) temporal summation of pain (TSP) using 3 
different stimuli; (E) condition pain modulation using PPTs as the test stimulus (pressure CPM); and (F) CPM using HPTs as the test stimulus (heat CPM). Significant 
differences between MSS quartiles (eg, 4th = highest sensory sensitivity) and the referent MSS quartile (1st, lowest) are indicated (**p≤0.01 *p≤0.05) based on transformed 
data but graphs show original data for clarity.
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reported MSS, despite temperature tolerance being one of the 
items used to assess MSS. These results may suggest heigh-
tened MSS may serve as a risk factor for deep-tissue pain 
sensitivity. Contrary to our initial hypotheses, these relation-
ships were not clearly differentiated between static and 
dynamic QST and did not vary substantially between men 
and women. Thus, common influences on MSS and pain 
sensitivity may involve central mechanisms but are likely 
more complex than previously recognized.
Dynamic versus Static QST
There is a general consensus that dynamic QST provides 
indirect indicators of central pain processing,6,7,54,55 while 
static QST, such as pain thresholds, may involve a mix of 
peripheral and central components. Dynamic and static 
QST have been widely applied to measure pain sensitivity 
in clinical pain populations and to further infer the under-
lying mechanisms.6,8,56–58 For instance, PPT and TSP to 
mechanical stimuli have been predictive of factors 
Figure 3 Boxplots showing median (black bars) and 25th–75th percentiles (IQR boxes) of (A) local pain ratings between men and women from the saline infusion at 80 mL/ 
hr and (B) pressure pain thresholds (PPT) at the deltoid muscle are shown by sex-specific MSS quartiles. Significant sex-MSS interactions were observed for both conditions; 
yet the follow-up stratified analyses by sex only show the significant difference on saline infusion at 80 mL/hr in women between MSS quartiles (eg, 4th = highest sensory 
sensitivity) and the referent MSS quartile (1st, lowest) (*p≤0.05).
Figure 4 Odds ratios (ORs) and their associated 95% confidence intervals (CI) for experiencing: referred pain from the 4 intramuscular infusions, the presence of temporal 
summation (TSP (+)), and the absence of conditioned pain modulation (CPM (-)) to each stimulus in people with high (4th quartile) versus low (1st quartile) MSS. All ORs 
were adjusted for age, sex, BMI, and neuroticism. Orange symbols and lines highlight significant ORs (p≤0.05).
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associated with the fear-avoidance model, such as pain 
catastrophizing and pain-related disability.8 This supports 
the application of QST and its relevance to diverse aspects 
of the pain experience. As TSP and CPM are widely 
accepted as measures reflecting central facilitation and 
inhibition of pain,6 the associations observed in our study 
may indicate that noxious and non-noxious sensory pro-
cessing may be linked centrally, even prior to the onset of 
a clinical pain syndrome. However, we cannot rule out that 
peripheral nervous system sensitivity may also play a role 
in shaping the varying degrees of associations observed 
between MSS and pain sensitivity, based on the associa-
tions also observed with PPTs. Thus, more complex 
mechanisms than previously appreciated may underlie 
the integration, modulation, and processing of painful 
and non-painful sensory inputs.
When interpreting observed differences in QST, con-
sideration should be made regarding the underlying mea-
surement error, using criteria such as twice the standard 
error of measurement (SEM).59 For example, two PPTs 
and the pressure CPM were significantly different 
between those in the highest versus the lowest MSS quar-
tiles. Prior research has reported a SEM for PPTs as 20.6 
kPa.59 We observed PPT differences (Q4 versus Q1) of 
59.4 and 81.8 kPa for the foot and leg locations which 
exceed this 2*SEM criteria (ie, 41.2 kPa). This suggests 
that in addition to being statistically meaningful, these 
PPT difference may be interpreted as real, measurable 
differences between the two extreme MSS groups. 
However, the pressure CPM difference (Q4 versus Q1) 
was only 34.3 kPa, which while larger than the SEM does 
not exceed 2*SEM. Instead, many investigators simply 
characterize the absence or presence of CPM rather than 
its magnitude. The 8-fold decrease in pressure CPM inci-
dence in MSS Q4 versus Q1 reveals the high risk of 
developing compromised central inhibition to pain in 
highly sensitive people.
Deep-Tissue versus Cutaneous Pain 
Sensitivity
The distinction between deep- and superficial-pain sensi-
tivity and MSS was not anticipated, as there is little prior 
work for comparison. One prior study with a small sample 
of healthy adults (n=30) also observed no relationship 
between heat CPM and sensory over-responsiveness, but 
conversely found higher heat pain ratings in those with 
greater over-responsiveness to sensory inputs.21 While the 
previous study only partially supports our findings, our 
results suggest that MSS is differentially related to QST 
based more on the stimulus modality than the type of test 
performed.
Deep-tissue and cutaneous pain processing exhibit sev-
eral unique features that may contribute to or be associated 
with this finding. For example, while both muscle and 
cutaneous afferents project to similar lamina layers in 
dorsal horn,60,61 muscle afferents demonstrate greater 
probability of glutamate release and higher expression of 
AMPA receptors than cutaneous afferents.61 Additionally, 
tonic inhibition of sensory inputs to dorsal horn neurons is 
stronger for deep than cutaneous mechanical stimuli, indi-
cating differential descending modulation between deep- 
tissue and cutaneous signals.62 Clinically, deep-tissue pain 
is perceived differently, often diffuse and described as 
aching and cramping, while cutaneous pain is well loca-
lized and frequently described as sharp, stabbing or 
burning.63–65 Further, deep, but not cutaneous, pain has 
been associated with autonomic symptoms.64,66 While it is 
not clear which, if any, of these differences may be rele-
vant to the unique shared variance observed between deep- 
tissue QST and MSS, the observed relationships suggest 
assessment of MSS in musculoskeletal pain conditions 
may have clinical value.
Potential Shared Brain Regions
While identifying the exact CNS pathways or regions 
responsible for this shared relationship between MSS and 
pain sensitivity is beyond the scope of this study, multiple 
candidate neurophysiological substrates have been identi-
fied. Brain regions involved in both painful and non- 
painful aversive stimuli processing include: thalamus, 
middle and posterior cingulate cortices, anterior insula, 
dorsal striatum, dorsomedial prefrontal cortex, posterior 
cingulate cortex, hippocampus, and midbrain areas.67–70 
More specifically, the thalamus is involved in modifying 
noxious and non-noxious sensory signals, with integration 
of, and communication between, multiple sensory 
pathways.71 Interestingly, all senses except olfaction 
directly transmit sensory information from the thalamus 
to the cerebral cortex.72,73 Structures in the limbic system, 
such as the insula, cingulate and medial prefrontal cortex, 
respond to both noxious inputs and a wide range of other 
sensory and affective events.74–76 A subset of the rostral 
ventromedial medulla neurons, known as pain-modulating 
neurons, not only respond to noxious heat but also bright 
lights, providing another potential convergence site for 
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noxious and non-noxious signal processing.68 However, 
this does not readily match the lack of association 
observed between heat pain sensitivity and somatosensory 
amplification in the current study, nor similar results found 
involving heat TSP or CPM in individuals with and with-
out elevated multisensory sensitivity.13,21 Whereas, 
healthy individuals with greater sensory sensitivity 
reported higher pain ratings to noxious stimuli than those 
without.21 Accordingly, the underlying mechanisms 
explaining the potential shared variance between noxious 
and non-noxious sensitivity remain unclear.
MSS as a Potential Risk Factor for 
Chronic Pain
Prior studies have demonstrated associations between ele-
vated sensory sensitivity and pain in select clinical 
conditions.11,15 Similarly, higher proportions of indivi-
duals with fibromyalgia,12,77 migraine,78 and complex 
regional pain syndrome16 exhibit heightened MSS com-
pared to healthy adults. Bar-Shalita suggests this evidence 
supports the role of MSS as a risk factor.16 Yet, these 
studies are unable to differentiate whether the experience 
of pain sensitized the CNS, thereby producing amplified 
sensory perception, or whether multisensory hypersensi-
tivity precedes the development of the pain condition. 
Certainly, the relationships between pain and sensory sen-
sitivity may differ when the CNS is in a sensitized state. 
However, our findings that highly sensitive healthy indivi-
duals experience heightened deep-tissue pain sensitivity 
support the possibility that MSS may be a risk factor for 
chronic pain. While relatively little is known of the risk 
profile associated with heightened MSS, patients charac-
terized with amplified sensory sensitivity, such as autism 
spectrum disorder, have also been identified as having 
compromised endogenous pain modulation.79,80 Future 
longitudinal studies are needed to clarify the role of MSS 
as a chronic pain risk factor.
Potential for Response Bias
Self-reported MSS and self-reported pain could be 
related simply in part due to reporting biases or due to 
elevated negative affect contributing to a heightened per-
ceived negativity overall. However, our results do not 
support this possibility. The relationship between MSS 
and deep-tissue pain sensitivity was not simply explained 
by neuroticism, a personality trait that is characterized 
by negative emotions such as anxiety, guilt, fear and 
depression.81 Indeed, neuroticism is correlated with self- 
reported sensory processing sensitivity,24,82 pain 
sensitivity,83 and we observed higher neuroticism scores 
in people with the highest MSS scores. However, the 
muscle and deep-tissue mechanical pain sensitivity 
assessments remained significantly related to MSS even 
after adjustment for neuroticism, indicating that negative 
emotionality is not the driving factor in this relationship. 
This finding is consistent with previous findings that 
self-reported sensory sensitivity remained strongly asso-
ciated with greater activation in brain areas involved in 
high-order visual processing after controlling for neuro-
ticism and introversion.84 Despite several differences in 
methodology, including the tool to assess sensory sensi-
tivity and the means of assessing non-noxious stimuli 
processing, our studies collectively support that these 
findings are not simply due to confounding from dispro-
portional negative emotionality. Further, the significant 
relationships observed between MSS and select QST did 
not only occur based on subjective pain ratings, but also 
by indicating differences in stimulus intensity threshold 
(ie, in kPa or degree units) to produce pain thresholds 
and CPM. This, along with the unique findings that self- 
reported MSS only predicted pressure-based QST but no 
other cutaneous forms of QST, further substantiates that 
reporting bias is not a likely explanation.
Study Limitations
Several limitations of this study are worth noting as they 
may limit generalizability. First, our population was pre-
dominantly Caucasian. Second, the sample sizes varied 
across QST assessments, such that the deltoid vs lower 
extremity PPT differences may be due to differences in 
study power. However, the larger effect sizes for deep- 
tissue versus cutaneous QST regardless of sample size 
suggest these results are robust. Additionally, subjects 
who volunteer to do pain studies may be less pain 
sensitive or fearful than the general population, yet our 
study still observes a significant relationship between 
increased sensory sensitivity and higher deep-tissue 
pain sensitivity. Lastly, MSS was assessed using 
7-items from the SSAS, a self-report instrument that 
does not involve assessments of taste, light or tactile 
sensitivity which are common sensations in daily life. 
However, currently, there is no gold-standard instrument 
for measuring MSS that cover all primary senses, parti-
cularly a brief and freely available instrument focusing 
on sensory sensitivity and not confounded by other 
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constructs such as coping strategies or avoidance beha-
viors. Future studies to evaluate available MSS tools and 
potentially develop improved MSS metrics are 
warranted.
Conclusions
Overall, this study uniquely demonstrates that MSS 
assessed in a pain-free state is related to both static and 
dynamic deep-tissue QST, indicating this relationship does 
not require the presence of chronic pain. Whether more 
generalized and magnified associations could also occur 
across modalities when in a more sensitized CNS state, as 
may occur with chronic pain, remains unknown. Our study 
provides a baseline reference highlighting a link between 
MSS and pain sensitivity that may serve as a comparison 
to future assessments involving chronic pain and the con-
tributions of MSS to the pain experience. Further, the 
parallel relationships between MSS with static and 
dynamic QST, but only with pressure stimuli, observed 
in our study suggests the MSS-pain interaction involves 
more complex mechanisms which may not be limited to 
central components. Given the intrinsic MSS-pain associa-
tions demonstrated in our findings, with the higher pre-
valence of elevated MSS in select chronic pain conditions, 
the link between MSS and pain sensitivity may play 
a larger role in the development or maintenance of chronic 
pain than previously recognized. Finally, this study inves-
tigating pain-free populations paves the way for further 
research in this important area of predicting chronic pain, 
particularly central sensitization or nociplastic pain.
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